Literature DB >> 10979695

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.

M D Hill, P A Barber, A M Demchuk, A M Buchan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10979695      PMCID： PMC1118286     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Acute ischaemic stroke.

Authors:  G Gubitz; P Sandercock
Journal:  BMJ       Date:  2000-03-11

2.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors:  W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Authors:  G W Albers; V E Bates; W M Clark; R Bell; P Verro; S A Hamilton
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

4.  Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.

Authors:  A M Buchan; P A Barber; N Newcommon; H G Karbalai; A M Demchuk; K M Hoyte; G M Klein; T E Feasby
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

5.  Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke.

Authors:  A G Dyker; D G Grosset; K Lees
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

6.  Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke.

Authors:  R J Butterworth; A Cluckie; S H Jackson; M Buxton-Thomas; P M Bath
Journal:  Cerebrovasc Dis       Date:  1998 May-Jun       Impact factor: 2.762
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.